Impact of G-CSF prophylaxis on the occurrence of neutropenia in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel.


Ozguroglu M., Oudard S., Sartor A. O. , Hansen S., Machiels J. H. , Shen L., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.29, 2011 (SCI İndekslerine Giren Dergi) identifier